Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06173401 · ClinicalTrials.gov registry record · Phase 3
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
A Phase 3 study of Spinal Metastases, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 274
- Enrollment target
- 1
- Study location
NCT06173401 is a Phase 3 study of Spinal Metastases that is actively recruiting participants, run by Stanford University. The registered enrollment target is 274 participants, above the 63-participant average among 5 other Spinal Metastases trials with a reported enrollment target (335% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06173401, a Phase 3 study of Spinal Metastases, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 274 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether fractionated Stereotactic radiosurgery (SRS) for spine metastases is associated with improved local tumor control compared to single-fraction SRS. Patients will be randomized to treatment with spine SRS using either 22 Gy in 1 fraction or 28 Gy in 2 fractions.
Conditions Studied
Interventions
- RADIATION Single-fraction spine SRS
- RADIATION Multi-fraction spine SRS
Study Locations (1)
California
- Stanford University School of Medicine - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2023-12-18 |
| Est. Completion | 2028-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06173401
The ClinicalTrials.gov registry entry for NCT06173401 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 274 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 63-participant average among 5 other Spinal Metastases trials with a reported enrollment target (335% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Metastases appearing as the primary indexed condition, and to 2 interventions - of which Single-fraction spine SRS is the first listed.
NCT06173401 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06173401 about?
NCT06173401 is a clinical study titled "Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases". The goal of this study is to determine whether fractionated Stereotactic radiosurgery (SRS) for spine metastases is associated with improved local tumor control compared to single-fraction SRS. Patients will be randomized to treatment with spine SRS using either 22 Gy in 1 fraction or 28 Gy in 2 fra...
What is the current status of trial NCT06173401?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 274 participants. The study started on 2023-12-18. Estimated completion is 2028-12.
What conditions does trial NCT06173401 study?
This clinical trial studies the following conditions: Spinal Metastases.
What interventions are being tested in trial NCT06173401?
The interventions under investigation include: Single-fraction spine SRS (RADIATION), Multi-fraction spine SRS (RADIATION).
Who is sponsoring clinical trial NCT06173401?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06173401 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
D20054;LITT for Spine Tumors
RECRUITING · NA
-
A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy
ACTIVE NOT RECRUITING
-
Validation of Novel Predictive Score for Patients With Spinal Metastases
COMPLETED
-
Intra-arterial Chemotherapy for Spinal Metastases
COMPLETED · Phase 1
-
Stereotactic Body Radiotherapy for Spine Tumors
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.